Trials / Completed
CompletedNCT00566150
Levetiracetam in the Management of Bipolar Depression
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A 6-week outpatient, double-blind, placebo-controlled, add-on trial to investigate the effects of levetiracetam on depressive symptoms in bipolar depressed patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levetiracetam | Flexible dose up to 2500mg per day, for 6 weeks. |
| DRUG | Placebo | Flexible dose up to 2500mg per day, for 6 weeks. |
Timeline
- Start date
- 2005-10-01
- Primary completion
- 2008-08-01
- Completion
- 2008-08-01
- First posted
- 2007-12-03
- Last updated
- 2020-03-31
- Results posted
- 2015-11-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00566150. Inclusion in this directory is not an endorsement.